Reuters exclusively reported that a U.S. lawmaker involved in health policy has asked the Food and Drug Administration why it did not inspect Elon Musk’s Neuralink before allowing the brain implant company to test its device in humans.
Related stories
Exclusives | Americas
Read more
How bond vigilantes could check Trump’s power
16 January 2025
News First | Americas
Read more
Meta warns India antitrust ruling could force roll back of features, hurt business
15 January 2025
News First | Americas
Read more